Anand Patel: Interesting article on adults over sixty years old with CBF-AML treated with intensive chemotherapy
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X, about recent article published in Haematologica:
Authors: Federico Mosna, Erika Borlenghi, Mark Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio, Felicetto Ferrara, Guido Marcucci, Roberto Cairoli, Elizabeth A. Morgan, Carmela Gurrieri, Cecilia C.S. Yeung, H. Joachim Deeg, Debora Capelli, Anna Candoni, Jason R. Gotlib, Monia Lunghi, Sheeja Pullarkat, Francesco Lanza, Sara Galimberti, Fabio Forghieri, Adriano Venditti, Moreno Festuccia, Ernesta Audisio, Denise Marvalle, Gian Matteo Rigolin, Giovanni Roti, Eros DiBona, Giuseppe Visani, Francesco Albano, Ann-Kathrin Eisfeld, Peter Valent, Gerwin Huls, Gautam Borthakur, Mauro Krampera, Giovanni Martinelli, Nicolaus Kröger, Alessandra Sperotto, Michele Gottardi.
”Interesting article in Haematologica on adults over sixty years old with core-binding factor acute myeloid leukemia (CBF-AML) treated with intensive chemotherapy.
- 84% complete remission rate after induction.
- 45% overall survival at five years (thirty-three percent in patients over seventy years old).”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023